SUWANEE, Ga., Sept. 15, 2017 -- Digirad Corporation (NASDAQ:DRAD), today announced that it will present at the Sidoti & Company Fall 2017 Conference on Thursday, September 28, 2017, at the New York Marriott Marquis hotel in Times Square, New York City.
During the presentation, taking place at 3:05 PM (EDT), Matt Molchan, President and CEO, will provide an overview of the Company’s business. Mr. Molchan and Mr. Jeff Keyes, Digirad’s CFO, will also be available to meet with investors on-site at the conference that day.
The presentation and live webcast will be available from the Events & Presentations link on the Investor Relations page of the Digirad website at www.digirad.com.
About Digirad
Digirad delivers convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis. Digirad’s diverse portfolio of mobile healthcare solutions and medical equipment and services, including diagnostic imaging and patient monitoring, provides hospitals, physician practices, and imaging centers throughout the United States access to technology and services necessary to provide exceptional patient care in the rapidly changing healthcare environment. For more information, please visit www.digirad.com.
About Sidoti & Company
Sidoti & Company, LLC is Wall Street’s preeminent provider of equity research generally focused on companies with market capitalizations of under $3 billion. They cover over 250 companies across a range of industries. The companies covered by their traditional research typically have a history of profitability, maintain strong balance sheets, and tend to have limited, if any, coverage by other Wall Street firms.
For those interested in attending, please contact Caitlin Adams at [email protected] or visit https://www.meetmax.com/sched/event_43487/~public/conference_register.html?event_id=43487&bank_access=0 for more information.
For more information contact:
Jeffry Keyes
Chief Financial Officer
858-726-1600
[email protected]


Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Apple Turns 50: From Garage Startup to AI Crossroads
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 



